# DESCRIPTION

## TECHNICAL FIELD

## BACKGROUND ART

## DISCLOSURE

### Technical Problem

### Technical Solution

### Advantageous Effects

## DETAILED DESCRIPTION OF THE INVENTION

### MODE FOR CARRYING OUT THE INVENTION

### Test Example 1: Increase in Anti-Inflammatory Macrophages by bvPLA2

### Test Example 2: Alleviation of Inflammatory Environment by bvPLA2

### Test Example 3: Oil Red O Staining

### Test Example 4: Experimental Animals

### Test Example 5: Regulatory T Cell Depletion (Treg Depletion)

### Test Example 6: Quantitative Real-Time PCR

### Test Example 7: H&E Staining

### Test Example 8: Statistical Analysis

## Example 1: Effects of bvPLA2 of Reducing Adipose Tissue Weight and Body Weight

## Example 2: Influence of bvPLA2 on Body Weight and Adipose Tissue Weight of CD206-Deficient and Regulatory T Cell-Deficient Mice

## Example 3: Hepatotoxicity/Nephrotoxicity Reducing Effects of bvPLA2

### Example 3-1: Effects of bvPLA2 of Ameliorating Hepatic Steatosis and Kidney Damage

### Example 3-2: Metabolic Dysfunction Alleviating Effect of bvPLA2

## Example 4: Effect of bvPLA2 of Inhibiting Macrophage Infiltration in Adipose Tissue

## Example 5: Effects of bvPLA2 of Modulating M1 or M2 Phenotype Markers and Adipogenic Factors

### Example 6: Comparison with Mellitin in Bee Venom

